The scientist’s investigation covers issues in Cell biology, Antigen, Immunology, Cytotoxic T cell and Immune system. His biological study spans a wide range of topics, including Interferon and Innate immune system. The various areas that Rongfu Wang examines in his Interferon study include Receptor and Ubiquitin.
Rongfu Wang combines subjects such as Molecular biology and Tumor antigen with his study of Antigen. He regularly links together related areas like Cancer in his Immune system studies. His research in Signal transduction intersects with topics in NLRX1, MDA5 and NLRC5.
Rongfu Wang focuses on Immunology, Cell biology, Antigen, Immune system and Interferon. His work is dedicated to discovering how Immunology, Cancer are connected with Adoptive cell transfer, Oncology and Cell therapy and other disciplines. The study incorporates disciplines such as Receptor and Ubiquitin in addition to Cell biology.
His Antigen study incorporates themes from Cytotoxic T cell, Tumor antigen and Cancer research. His studies deal with areas such as Epitope, T cell and Molecular biology as well as Cytotoxic T cell. In the subject of general Interferon, his work in Interferon type I is often linked to Plasmodium yoelii, thereby combining diverse domains of study.
His scientific interests lie mostly in Cancer research, Cell biology, Interferon, Signal transduction and Prostate cancer. His work deals with themes such as Carcinogenesis, Cancer, Cellular differentiation, SOX2 and Epigenetics, which intersect with Cancer research. His Cell biology research is multidisciplinary, incorporating elements of KLF2, Regulator gene and Gene expression.
His Interferon research includes elements of CD28, NFAT and Immune system. Rongfu Wang focuses mostly in the field of Immune system, narrowing it down to matters related to MDA5 and, in some cases, Innate immune system. His biological study focuses on Interferon type I.
His primary areas of investigation include Cell biology, Interferon type I, Signal transduction, DEAD Box Protein 58 and RNA interference. His Cell biology research is multidisciplinary, incorporating perspectives in RIG-I, Receptor and Interferon.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Construction of versatile low-copy-number vectors for cloning, sequencing and gene expression in Escherichia coli.
Rong Fu Wang;Sidney R. Kushner.
Gene (1991)
Toll-Like Receptor 8-Mediated Reversal of CD4+ Regulatory T Cell Function
Gyangyong Peng;Zhong Guo;Yukiko Kiniwa;Kui Shin Voo.
Science (2005)
Tumor-specific human CD4+ regulatory T cells and their ligands: Implications for immunotherapy
Helen Yicheng Wang;Dean A. Lee;Guangyong Peng;Zhong Guo.
Immunity (2004)
Cancer therapy using a self-replicating RNA vaccine
Han Ying;Tal Z. Zaks;Rong Fu Wang;Kari R. Irvine.
Nature Medicine (1999)
Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes
Rong Fu Wang;Steven A. Rosenberg.
Journal of Experimental Medicine (1996)
NLRC5 Negatively Regulates the NF-κB and Type I Interferon Signaling Pathways
Jun Cui;Liang Zhu;Liang Zhu;Xiaojun Xia;Helen Y. Wang.
Cell (2010)
Cloning Genes Encoding MHC Class II-Restricted Antigens: Mutated CDC27 as a Tumor Antigen
Rong Fu Wang;Xiang Wang;Alicia C. Atwood;Suzanne L. Topalian.
Science (1999)
Regulatory T cells and cancer
Helen Yicheng Wang;Rongfu Wang.
Current Opinion in Immunology (2007)
Human tumor antigens for cancer vaccine development
Rong Fu Wang;Steven A. Rosenberg.
Immunological Reviews (1999)
Identification of a gene encoding a melanoma tumor antigen recognized by HLA-A31-restricted tumor-infiltrating lymphocytes.
Rong-Fu Wang;P. F. Robbins;Y. Kawakami;Xiao-Qiang Kang.
Journal of Experimental Medicine (1995)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
National Institutes of Health
National Institutes of Health
National Institutes of Health
Keio University
Houston Methodist
National Institutes of Health
National Institutes of Health
National Institutes of Health
Johns Hopkins University
University of Georgia
Tyndall National Institute
University of Iowa
Zhengzhou University
University of Florida
University of Copenhagen
Experimental Medicine and Biology Institute
Erasmus University Rotterdam
University of Bonn
Mayo Clinic
University of South Carolina
Ocean University of China
Oregon Health & Science University
University College London
St. Luke's International Hospital
Paracelsus Medical University